Cabaletta Bio, Inc.
CABA
$2.75
$0.041.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.72M | 28.39M | 29.57M | 31.40M | 31.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 185.52M | 179.40M | 172.24M | 163.42M | 149.87M |
| Operating Income | -185.52M | -179.40M | -172.24M | -163.42M | -149.87M |
| Income Before Tax | -181.32M | -175.43M | -167.86M | -158.52M | -144.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -181.32 | -175.43 | -167.86 | -158.52 | -144.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -181.32M | -175.43M | -167.86M | -158.52M | -144.29M |
| EBIT | -185.52M | -179.40M | -172.24M | -163.42M | -149.87M |
| EBITDA | -184.12M | -177.90M | -170.60M | -161.65M | -148.03M |
| EPS Basic | -1.56 | -1.96 | -2.28 | -2.53 | -2.71 |
| Normalized Basic EPS | -0.98 | -1.22 | -1.42 | -1.58 | -1.69 |
| EPS Diluted | -1.56 | -1.96 | -2.28 | -2.53 | -2.71 |
| Normalized Diluted EPS | -0.98 | -1.22 | -1.42 | -1.58 | -1.69 |
| Average Basic Shares Outstanding | 470.25M | 380.96M | 319.68M | 265.01M | 212.22M |
| Average Diluted Shares Outstanding | 470.25M | 380.96M | 319.68M | 265.01M | 212.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |